Skip to content
FIND A BIOALPS ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

On this page you will find all the latest news regarding BioAlps affiliated members and life sciences activities in western Switzerland.

All the latest press articles featuring BioAlps can be found in our Media Center on our About page.

Selexis - kbi

KBI Biopharma SA and Selexis SA inaugurated a new facility in Geneva

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development…

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l'Innovation Technologique (FIT)

The canton of Vaud keeps on backing the FIT

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l’Innovation Technologique (FIT)  …

Lonza, stein

Lonza opens a new production facility in Stein (CH)

Lonza plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH). CHF 500 million will…

Vaud Investments Life Sciences

Vaud invests CHF 178 Million in Life Sciences

To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne…

CSEM and Clexbio Team

Supervene: growing humain vein tissues

ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins…

Magali Bischof, Secretary General of BioAlps (L) with George Kouvas Chief Technology Officer at the Wyss Center (R)

Wyss Center joins life sciences cluster BioAlps 

The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives,…

Madiha Derouazi (right) and Elodie Belnoue (left)

Geneva researcher wins European Inventor’s Award

Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded…

ten23health

ten23health is building a new facility in Visp

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a…

Ecotope 1

Ecotope, the new EPFL Innovation Park’s project

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together…

ORama VR

A CHF 12 Million Innosuisse Grant for a VR Surgical Training Method

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A….

Limula wins a prestigious EIC grant of €4.7 million

By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.

AlveoliX Swiss Medtech Award

AlveoliX wins the Swiss Medtech Award 2022

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019,…

Solange Peters Chuv

CHUV strengthens its strategy to fight cancer

The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The…

BioAlps OM Pharma 4à6

BioAlps at OM Pharma

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma…

Cityva 3D

Cytiva opens a new production site in Grens (VD)

Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022.   The site will manufacture…

Top Swiss Startups

Votes are open for the TOP 100 Swiss Startups! 

What is your favorite swiss startup?   Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative…

Antoine Geissbuhler BioAlps President

Pr. Antoine Geissbuhler is the new BioAlps’ President

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster…

Alithea Genomics

Alithea Genomics closes a CHF 1 million seed round

Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of…

Dr. Andrea Pfeifer Ac Immune SA

Dr. Andrea Pfeifer received the Aenne Burda Award

The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease  …

Kodiak Sciences and Lonza open a new facility in Visp

Kodiak Sciences and Lonza open a new facility in Visp

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases,…

Spark centre for movement science and technologies

SpArk, the centre for movement science and technologies, is born!

This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The…

Hansjorg Wyss

Hansjörg Wyss, the life sciences philanthropist

On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great…

Onward 1

ONWARD’s Neurostimulator Restores Mobility for Patients with Spinal Cord Injury

This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the…

HemostOD

HemostOD creates ex vivo blood platelets

HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100…

Biotech

Swiss biotech companies attracted investments of $3.33 billion in 2021

Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited…

Claude Clément

Podcast: Claude Clément

BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do…

Debiotech

A revolutionary home dialysis device made in Switzerland

The VersiTMPD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance

Merck Serono Christophe Martin

Merck Serono improves quality control with IA

Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit   In any factory,…

Limula Ceidos Stemmatters

EUR 1 million Eurostars grant for Limula and Ceidos

The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14…

startup invest

Switzerland is high on the financing of medical startups

Switzerland ranks fourth in Europe in terms of the number of deals behind Britain, Germany and France.   Last year,…

Plair SA raised CHF 2,7 million

A grant to fund the Rapid-C Real-Time Microbial Detector    Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF…

Artiria Medical

Artiria Medical raised CHF 3.8 million to improve stroke treatment

Artiria Medical, a swiss neurovascular start-up, raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective…

Neuro Restore

An electronic implant helps a bedridden patient to walk again

Researchers at the NeuroRestore research center in Lausanne Switzerland helped a patient suffering from a neurogenerative disease to leave her…

Neurosoft Bioelectronics

Neurosoft Bioelectronics raised CHF 3 Million

The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain   Neurosoft Bioelectronics, an early-stage…

Western Switzerland, paradise for Life Sciences Companies

18 new foreign life sciences companies settled in our region in 2021   Last year, according to GGBa’s annual report,…

Tech4Eva

Tech4Eva 2022 cohort

13 growth-stage startups and 15 early-stage start-ups and projects have been selected for the 2022 program.   Tech4Eva is an…

Nanolive raises US $ 20 million

The Swiss company is a pioneer in the development of live-cell imaging, and digital analytical solutions The swiss leading live-cell…

Venturelab Medtech Team 2022

Venture Leaders Medtech Team 2022

Ten startups have been chosen by a jury of investors as the Swiss National Startup Team for Venture Leaders Medtech…

MEC at Campus Biotech

A MEG plateform at Campus Biotech in 2022

A new device for brain research at the Campus Biotech   Next summer, the Human Neuroscience Platform (HNP) at Campus…

Wyss Center

Completely locked-in man uses brain-computer interface to communicate

Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals   Completely paralyzed…

Ana Pinto

INTERVIEW – Ana Pinto

🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie…

Parithera Device

Parithera raises CHF 100 000 from FIT

The Foundation for Technological Innovation (FIT) has granted a CHF 100’000 Tech Seed loan to Parithera and its ExTrace Dx…

Nagi Bioscience

Nagi Bioscience won a € 2,5 million grant from the EIC Accelerator

The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology   Nagi Bioscience has been bestowed the prestigious and highly…

Swiss Medtech Ukraine

Medical devices for Ukraine

The Ukraine Embassy launches an appeal for donations   Collection points in Switzerland The war in Ukraine has thrown millions…

SEED Biosciences raises CHF 400 000

The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one.   The device, called…

Parkinson Disease

A gene could prevent Parkinson’s disease

A mutation in the Fer2 gene causes motor deficiencies in flies   The laboratory of Emi Nagoshi, Professor in the…

Monthey BioArk

BioArk Monthey is expanding

A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first…

Ceidos Founders

Ceidos revolutionises cell culture

The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that…

Superlab Lausanne

Superlab Suisse Lausanne

A coworking space designed for scientists   Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in…

Unige breast Cancer

UNIGE: Fighting breast cancer cells growth

A low rate of a specific protein triggers tumors development. A UNIGE team found the counter-attack   In about 2/3…

Li Tang CEO Leman Biotech EPFL

$11 million for EPFL spin-off Leman Biotech

A protein that boosts the immune system can cure 90% of cancer in mice   Immunotherapy, which aims to boost…

GSK Haleon

GSK’s new company Haleon will have a site in Nyon

The pharmaceutical group GlaxoSmithKline creates Haleon, a new company from the separation of its consumer healthcare business. This entity will…

Neo Medical

Neo Medical raises $20 million for its AR technology for spine surgery

Swisscom Ventures is the lead investor in this round. The Vaud-based company will use the new funds to accelerate the…

Massimo Nobile

INTERVIEW : Massimo Nobile

🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.

MindMaze

MindMaze secures a $105 million financing round

After a banner-year, the Lausanne-based company MindMaze secures $105 Million Financing, led by Concord Health Partners, and initiates American Hospital…

Leucine Project

Leucine project: a new hub for life sciences in Lausanne

New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new…

Carrol-Plummer-and-Nigel-Wallbridge

PhytlSigns raises CHF 500 000 for a plant monitoring system

The ‘Fitbit of Plants’ uses AI sensors to monitor crops   The startup Vivent provides growers with a technology to…

Miniature Raphaël Conz

INTERVIEW : Raphaël Conz, BioAlps vice-president

🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of…

Animal Testing

Swiss voters reject ban on animal testing

Voters have rejected a complete ban on experiments on living creatures in Switzerland.   The idea of putting an end…

Adaptyv Biosystems

Adaptyv Biosystems raised CHF 2.5 million in a pre-seed funding

Adaptyv Biosystems is to create the world’s largest protein design database   The company, based in Biopôle in Epalinges, is…

Genolier Innovation Hub

Genolier Innovation Hub

A new medical Innovation Hub will open in 2024   “This is not a real estate project to house the…

Haya Therapeutics

Haya Therapeuthics closes US$ 5 Million seed extension

The Lausanne-based company will open a branch office in San Diego to continue its growth   HAYA closes US$ 5…

Miniature Claude Clément

INTERVIEW : Claude Clément, BioAlps President

  🔺 Claude Clément is BioAlps President. According to him, multiculturality is why Switzerland🇨🇭 has become so successful in the…

Science first, politics second

The “Stick to Science” petition aims to allow Swiss and British researchers to remain in Horizon Europe programme.   The…

.NeuroRestore

An implant could cure paralysis

A new implant enables patients with a complete spinal cord injury to stand, walk and even swim    Michel Roccati,…

La Source

La Source Launches H4

La Source opens an innovation platform dedicated to care and health in Vaud (Switzerland).   The H4 “Hands-on Human Health…

Distalmotion

Distalmotion | $ 90M to make sense of robotic surgery

A partnership of medtech pioneers and company-builders   Distalmotion, based in Lausanne (Switzerland), Revival Healthcare Capital and 415 CAPITAL announced…

Takeda

Takeda | New building in Neuchâtel estimated at CHF 30 million

The pharmaceutical group Takeda wishes to increase the production capacity of its site in Neuchâtel (Switzerland) and will build a…

ADC Therapeutics

ADC Therapeutics | $30 million in new partnership deal

Development & commercialisation of ZYNLONTA in Japan   ADC Therapeutics SA, a commercial-stage biotechnology company improving the lives of those…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the newest resources in SIB’s infrastructure portfolio for the Life Sciences

Development of national secure platforms, leading open science databases & software tools    The Swiss Institute of Bioinformatics (SIB)’s mission,…

Antio Biosciences

Antion Biosciences | Exclusive collaboration & global license agreement with Allogene Therapeutics

Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products…

Adiposs SA

Adiposs | Raised CHF 1.8M 1st closing of its Pre-Series A round

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for…

Venture Kick

Record-high startup support for Swiss university spin-offs in 2022

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841…

Magali Bischof

Magali Bischof to become the new General Secretary of BioAlps

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs…

GeNeuro

GeNeuro | CHF 6.7 million for the development of COVID-19 medicines

GeNeuro received CHF 6.7 million in funding for the development of temelimab against Long-COVID   GeNeuro, a biopharmaceutical company developing…

Merck & Chord Therapeutics

Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics

Merck invests into Cadribine to try to cure rare neuroinflammatory diseases   Chord Therapeutics (Chord), a clinical-stage biopharmaceutical company developing…

Xsensio

Xsensio | CHF 4.2 million to accelerate market launch

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the…

D36.ch

Intellias and D36.ch join forces

In November 2021, Intellias, a technology partner of Fortune 500 companies and top-tier organizations, and D36.ch, an innovative Swiss healthcare startup, announced their strategic partnership. The companies are joining efforts to build a bridge between the Swiss digital health market and world-class IT services to reinforce customers’ digital strength by combining 360-degree domain expertise with state-of-the-art software engineering solutions.

Biopôle SA

Biopôle | Partnership programme with Swiss Medical Network

Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private…

Sun genomics

Sun Genomics | Sets up European subsidiary in Fribourg (Switzerland)

1st establishment of a US company in Western Switzerland without prior in-person meeting   A first for the canton of…

Heidi.news | BioAlps: 20 years of innovation

Medical innovation & contribution to the future of medicine   On 30 November, 2021, Mrs Annick Chevillot (Heidi.news) has moderated…

HEIG-VD

Appointment of a new Full Professor at HEIG-VD

Underlines the ambition of the HEIG-VD to pursue its development in management applied to the health sector, both in the field of education and research

HealthCare Konnect

Deep Bio and HealthCare Konnect | Improving cancer diagnosis

Deep Bio and HealthCare Konnect (HCK) partner to improve cancer diagnosis in Switzerland and North Africa   On 18 October…

OM Pharma

BioAlps | 20 years of innovation | OM Pharma

Investing, innovating and hiring in Switzerland to prevent infection worldwide   We are pleased to share with you our new…

Debiopharm

BioAlps | 20 years of innovation | Debiopharm

Debiopharm | We develop for patients   We are pleased to share with you our new testimonial series as part…

Ichnos

BioAlps | 20 years of innovation | Ichnos

Developing first-in-class bi-/trispecific antibodies to treat cancer patients   We are pleased to share with you our new testimonial series…

Swiss Pathogen Surveillance Platform

Creation of the Swiss Pathogen Surveillance Platform SPSP

Switzerland establishes a national infrastructure to track COVID-19 and its variants Discover the role of the Swiss Pathogen Surveillance Platform…

Pharmalp

BioAlps | 20 years of innovation | Pharmalp

Developing and distributing efficacious natural healthcare products   We are pleased to share with you our new testimonial series as…

CSL

BioAlps | 20 years of innovation | CSL Behring

Fast-tracking innovation through long-term mutual partnerships with academia   We are pleased to share with you our new testimonial series…

Vifor Pharma

BioAlps | 20 years of innovation | Vifor Pharma

On a mission to help patients live better, healthier lives   We are pleased to share with you our new…

BioArk

BioAlps | 20 years of innovation | BioArk

Strengthening the Life Sciences value chain from discovery to market   We are pleased to share with you our new…

HES-SO

BioAlps | 20 years of innovation | HES-SO

Supporting the Swiss economy with locally rooted training and applied research   We are pleased to share with you our…

Selexis

BioAlps | 20 years of innovation | Selexis

Selexis | Cell line development meets lab automation and robotics for biologic therapeutic manufacturing   We are pleased to share…

Fongit

BioAlps | 20 years of innovation | Fongit

Fongit | Switzerland’s premier startup incubator   We are pleased to share with you our new testimonial series as part…

SILAB

BioAlps | 20 years of innovation | SILAB

SILAB ǀ Dedicated to promoting a relevant and sustainable innovation in healthcare   We are pleased to share with you…

UNIL

BioAlps | 20 years of innovation | UNIL

UNIL | A commitment to transforming Life Sciences into concrete actions for the benefit of all   We are pleased…

CERN

BioAlps | 20 years of innovation | CERN

CERN | Unique technologies with a wide scope of applications   We are pleased to share with you our new…

Netsensing

BioAlps | 20 years of innovation | Netsensing

Netsensing | Saving lives through the detection of sleep apnea   We are pleased to share with you our new…

JAG

BioAlps | 20 years of innovation | JAG

JAG | Highly automated process plants for the pharmaceutical and biotech industries   We are pleased to share with you…

GGBa

BioAlps | 20 years of innovation | Greater Geneva Bern area

GGBa | The official investment promotion agency for Western Switzerland   We are pleased to share with you our new…

Gnubiotics

BioAlps | 20 years of innovation | Gnubiotics

Gnubiotics | Novel microbiome health solutions   We are pleased to share with you our new testimonial series as part…

GeNeuro

BioAlps | 20 years of innovation | GeNeuro

Fighting against neurodegenerative and autoimmune disease with antibodies   We are pleased to share with you our new testimonial series…

Neurix

BioAlps | 20 years of innovation | Neurix

Minibrain technology enabling efficient drug testing and development   We are pleased to share with you our new testimonial series…

Coat-X

BioAlps | 20 years of innovation | Coat-X

Thin-film encapsulation technology helping increase product reliability and miniaturisation effectiveness   We are pleased to share with you our new…

UCB

BioAlps | 20 years of innovation | UCB

UCB | Creating value for patients now and into the future   We are pleased to share with you our…

EPFL

EPFL | Research with animals

A necessity for scientific progress   Despite the many advancements in developing innovative alternative methods, animal testing still plays an…

Swiss Biotech Association

BioAlps | 20 years of innovation | Swiss Biotech Association

SBA | Representing the interests of the Swiss biotech industry   We are pleased to share with you our new…

Socorex

BioAlps | 20 years of innovation | Socorex

60 years of high-quality manufacturing of liquid handling instruments   We are pleased to share with you our new testimonial…

Debiotech

BioAlps | 20 years of innovation | Debiotech

Key medtech player fostering innovative medical software solutions and device development projects   We are pleased to share with you…

Biopôle

BioAlps | 20 years of innovation | Biopôle

High-quality support and valuable community for life sciences companies   We are pleased to share with you our new testimonial…

KATZAROV

BioAlps | 20 years of innovation | KATZAROV

Intellectual property for Life Sciences innovators   We are pleased to share with you our new testimonial series as part…

Incyte Bioplant

New Incyte bioplant opens in Switzerland

Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud   On 31 August 2021, Incyte, the US-based…

CSEM

BioAlps | 20 years of innovation | CSEM

Supporting the Life Sciences industry with cell-tech, biomonitoring and lab automation know-how   We are pleased to share with you…

iOnctura

BioAlps | 20 years of innovation | iOnctura

iOnctura | Better drugs to beat cancer resistance   We are pleased to share with you our new testimonial series…

Combioxin SA

Combioxin signs a worldwide licensing agreement

Combioxin has signed a worldwide licensing agreement with Eagle Pharmaceuticals Eagle Pharmaceuticals has entered into a worldwide licensing agreement with…

AC Immune

BioAlps | 20 years of innovation | AC Immune

Addressing the slow pandemic of neurodegenerative diseases   We are pleased to share with you our new testimonial series as…

Innovaud

BioAlps | 20 years of innovation | Innovaud

Connecting tech-oriented companies | Supporting cross-cutting innovation   We are pleased to share with you our new testimonial series as…

Geneus

BioAlps | 20 years of innovation | Geneus

Life Sciences innovation initiator | Transforming ideas & research into startups   We are pleased to share with you our…

SIB Swiss Institute of Bioinformatics

BioAlps | 20 years of innovation | SIB Swiss Institute of Bioinformatics

SIB | Supporting the Life Sciences community with Computational Biology and Bioinformatics know-how   We are pleased to share with…

Abionic

BioAlps | 20 years of innovation | Abionic

Nanotechnology to detect sepsis in 5 minutes from one drop of blood   We are pleased to share with you…

HEPIA Tissue Engineering Lab

BioAlps | 20 years of innovation | HEPIA Tissue Engineering Lab

Microtech tools meet novel integrated in vitro cellular model to help accelerate research    We are pleased to share with…

Lunaphore

Lunaphore | Top 10 Spatial Biology Companies

Lunaphore was selected as one of the top 10 spatial biology companies in the world   Lunaphore Technologies has been…

Fongit

FONGIT Innovation Fund selects four startups

FIF | FONGIT Innovation Fund Following the announcement of the creation of the FONGIT Innovation Fund (FIF), the foundation supporting…

Distalmotion

Distalmotion | Pioneering Hybrid Robotics in General Surgery

CHUV performed the world’s first hybrid robotic general surgery   Distalmotion & CHUV announced the successful start to a case series…

EBAMed

EBAMed | Prospective Imaging Study

First patient enrollment   EBAMed announced first patient enrolled in prospective imaging study with ultrasound guidance prototype in ventricular tachycardia…

SOPHiA GENETICS | Opts for Nasdaq IPO

Closing of $234 mio. Initial Public Offering & $20 mio. Private Placement   SOPHiA GENETICS SA (Nasdaq: SOPH), the creator…

Oncology

CHUV | A breakthrough in oncology

CHUV | Biomarkers which could save lives   Scientists at CHUV have identified cells which create metastasis in a tumour….

Merck

Merck | New Biotech Development Center

Merck reaches key milestone in the construction of its Biotech Development Center Announced in January 2020, Merck‘s new state-of-the-art biotech development…

Asceneuron

Asceneuron | Appoints new Board Member

Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases

Drug Discovery World

Drug Discovery World | Switzerland as a global biotech hub

Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued…

AC Biosciences

AC BioScience | Committed to fight against cancer

Interview with Andreas Schläpfer, CEO & cofounder   AC BioScience, the Vaud based company is a pioneer in the development…

EPFL

EPFL | A virus to identify small peptide mimics of antifreeze proteins

Scientists at EPFL (Polymers Laboratory) and the University of Warwick have used a virus to identify a peptide that can…

EPFL

EPFL | Next-generation implants will be biodegradable and non-invasive

Tissue grows back once the implant is gone   EPFL engineers have developed a neural interface that disappears harmlessly in…

CSEM

CSEM | Solid 2020 results despite the tough economic climate

Digital support to Gait Up    CSEM posted a solid financial performance in 2020 and made further progress on important technological…

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund | 1st venture fund dedicated to diabetes technology

CHF 50 million for diabetes ventures Launch of the first venture fund dedicated to diabetes technology, through a collaboration between…

UNIGE

UNIGE | How do immune cells get activated?

Decoding the activation mechanism of the CCR5 receptor By studying the structure of cellular receptors and of the molecules that…

EPFL

EPFL | Tailored optical stimulation for the blind

Stimulation of the nervous system with neurotechnology EPFL scientists in a European collaboration propose a personalised protocol for optimising stimulation…

CERN

CERN | CLEAR study paves the way for novel electron-based cancer therapy

High-energy electron beams can be focused onto deep-seated cancerous tumours   The study, conducted at CERN’s CLEAR test facility, demonstrates…

PharmaPlan

Pharmaplan (TTP Group) | New office in Visp close to Lonza

New office with 60 employees   In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another…

LABIOTECH.EU

Top 15 Swiss biotech startups making a difference in Europe

This article was written by Labiotech.eu with the support of BioAlps, the Greater Zurich Area, and Switzerland Global Enterprise (S-GE)….

Fondation Leenaards

Leenaards Foundation | Science Prize 2021

CHF 1.4 mio for biomedical research in the Lake Geneva region   The Leenaards Foundation has awarded Science Prizes to…

HEIG VD

HEIG VD | Rethinking the manufacture of cell & gene therapies

  HEIG-VD is joining forces with the EPFL and the University of Geneva (UNIGE) to take up the challenge of…

Embion

Embion | Nominated for the Swiss Economic Award 2021

The most important prize for young entrepreneurs in Switzerland   From dozens of applications, nine companies were nominated for the…

FONGIT

FONGIT Innovation Fund (FIF)

The first two beneficiaries of the FIF   The foundation supporting technological entrepreneurship in the canton of Geneva, FONGIT, announces…

EPFL

EPFL | How healthy is your digital twin?

Ethical & legal questions   Digital twins – a savvy combination of artificial intelligence and personal data – have already…

Venturelab

Venturelab | Venture Leaders Medtech 2021

Meet the Swiss national MedTech team   The Swiss National Startup Team has 10 new members: 10 startups were selected…

Abologix

Abologix | Wins CHF 150,000

Sum used to develop targeted antibodies for cancer patients   Abologix develops a new therapeutic option to treat lymphoma patients…

Rheon Medical

Rheon Medical | 1st implantation of the “Eyewatch” implant in Valais

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited…

UNIGE

UNIGE | Replicating patients’ tumours to test different treatments

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour…

SIB Swiss Bioinformatics Institute

SIB | A year of Swiss data science for life: activity report 2020

Welcome to new activity report of the SIB Swiss Institute of Bioinformatics, the nationwide organisation dedicated to biological and biomedical…

GGBa

GGBa | Geneva welcomes new global health investment advisory

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva…

EarlySight

EarlySight | Seed round closing

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million…

Selexis

Selexis | “Best Workplaces™ Switzerland” 2021

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that…

Heidi.news

Heidi.news | The Swiss Confederation reinvests in the development of Swiss vaccines

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research…

Switzerland Global Enterprise

S-GE | The new EU Medical Device Regulation (MDR) came into force on 26 May 2021

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date…

Haya Therapeutics

Haya Therapeutics | Completes CHF 18 mio. seed financing

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific…

CERN

CERN | Innovate in healthcare with CERN

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT)…

Biopôle

Biopôle | New start-up fund to foster early innovation in the Life Sciences

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes…

EPFL

EPFL | Cancer cells hijack the 3D structure of DNA

A novel algorithmic approach on cancer cells   Scientists at EPFL and UNIL have used a novel algorithmic approach on…

bNovate

bNovate | Fundraising to expand commercial activities internationally

CHF 5 million fundraising bNovate Technologies SA, a Swiss company specialised in industrial microbiology aiming at increasing the safety of…

Flowbone

Flowbone | Winner of the 2nd round of the Venture Kick competition

Prize of CHF 50’000   EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The scientists…

Lonza

Lonza | Invests CHF 650 million in Visp

Significant investments to expand its mammalian drug substance manufacturing facilities in Visp The Lonza‘s expansion in Visp (Valais, Switzerland) will…

Swiss Biotech Center

Swiss Biotech Center | Covid-19: a 2nd generation vaccine in preparation in Monthey

Strategic collaboration agreement between Swiss Biotech Center & Berna Biotech Pharma The Swiss biotech companies Berna Biotech Pharma Gmbh and…

Alithea Genomics

Alithea Genomics | Has been awarded CHF 150,000

CHF 150,000 for RNA sequencing to boost biomedical research Lausanne-based Alithea Genomics, developing a novel technology that enables a high…

Debiopharm

Debiopharm | Launch of the “Innovation DEbiopharm Academia Léman” (IDEAL)

The Lemanic region as a hub for Life Science innovation   Debiopharm a Swiss biopharmaceutical company based in Lausanne, announced the…

Calciscon

Calciscon | Raised CHF 2.5M Series A

Commercialisation of the T50 Test to drive more efficient therapies for renal patients    Calciscon AG announced  the closing for…

Gondola Medical Technologies

Gondola Medical Technologies | New research momentum

Building clinical research momentum with 500’000 CHF Tech Growth loan Clinical research and studies demonstrate Gondola Medical Technologies AMPS therapy’s…

EPFL

EPFL | New “brain stress test” for evaluating the mental status of patients with Parkinson’s disease

Awakening “ghosts” in patients with Parkinson’s   EPFL scientists are developing a completely new “brain stress test” for evaluating the…

HCK

Healthcare Konnect (HCK) | Distribution agreement signed with VUNO

Introduction of AI suite in Swiss medical institutions   South Korean Medical AI trailblazer, VUNO, and Swiss medical distribution company,…

Biopôle

Biopôle | Neurotechnologies offer new hope for patients with Parkinson’s disease

3 Biopôle-based companies are striving to find innovation solutions   CHUV-NeuroTech, ND BioSciences & Gondola Medical Technologies , 3 Biopôle-based companies are…

Mybiopassport

CoreMedica Europe | Intercantonal collaboration on SARS-COV-2 detection in saliva 

Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method   CoreMedica Europe a Swiss biotechnology company based…

HEIG VD

HEIG – VD | Innovations in health care

A brand new tool is available to map the organisational impacts    Innovation in health care is shaking up and…

ADC Therapeutics

ADC Therapeutics | FDA Approval of ZYNLONTA™

FDA Approval of ZYNLONTA™ in Relapsed or Refractory Diffuse Large B-Cell Lymphoma   ADC Therapeutics SA announced that the Food…

Swiss Biotech Association

Swiss Biotech Association | Record year for Western Switzerland’s biotech industry

An attractive, dynamic & ever-growing life sciences ecosystem   Biotechnology companies based in Switzerland have experienced record investments in the…

EPFL

EPFL | New hydrogel can repair tears in human tissue

An injectable gel that can attach to various kinds of soft internal tissues    EPFL scientists have developed an injectable…

Ferring

Ferring Pharmaceuticals | Ferring Biologics Innovation Centre opens at Biopôle

A new hub for biologics R&D in Western Switzerland   On 1 April 2021, the research-driven biopharmaceutical group Ferring Pharmaceuticals…

GGBa

GGBa | 85 new foreign companies in Western Switzerland in 2020

In 2020, 85 new foreign companies set up shop in Western Switzerland, supported by Greater Geneva Bern area (GGBa) and the…

Lonza

Lonza | Hiring of 1200 people in Visp

Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the SIB Remarkable Outputs 2020

Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.

CSEM

CSEM | 2020 Digital Journey Award

Gait Up & Definition12 win the 2020 CSEM digital journey award   CSEM has announced the two winners of its…

SIB Swiss Bioinformatics Institute

SIB | Creation of a Swiss SARS-CoV-2 Data Hub 

Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub  Over the past weeks and with the threat of emerging…

Inait

Inait | Joined the Scale Up Vaud program

Artificial Brain Intelligence (ABI)   An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud…

Netsensing Technology

Netsensing Technology | SmartEEs2 (EU H2020) contracting phase

The EU consortium will reinforce its penetration to global market & its position with EU partners   Incubated at Microcity,…

Terapet

Terapet | Proton therapy

CHF 1.5M of non-dilutive funding   Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer,…

Adiposs

Adiposs | Green light for clinical trials

ImageBAT   Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK,  the Geneva…

CHUV HUG EPFL

CHUV, EPFL, HUG | AI now sees & hears COVID in your lungs

Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds   DeepChest…

Asceneuron

Asceneuron SA | Awarded by the Alzheimer’s Drug Discovery Foundation

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021

EPFL Innovation Park

EPFL Innovation Park |  First Femtech accelerator in Switzerland (Tech4Eva)

In honor of Women’s International Day, EPFL Innovation Park is announcing the launch of Tech4Eva, the first Femtech accelerator in Switzerland,…

Biopôle

Biopôle | Hosts the 1st branch of Superlab Suisse

The centre will open by the end of the 2nd quarter of 2021   Superlab Suisse AG, a Zurich-based private…

EBAMed

EBAMed | Swiss-based medtech startup

New CEO   EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist…

Biopôle

Biopôle | 3 new buildings by 2024

Life Sciences cluster   The Biopôle site continues its strong development with the construction of three new buildings. By 2024,…

Canton Neuchâtel

New training course: chemical & pharmaceutical production technologist

Close collaboration between biopharmaceutical companies & Canton de Neuchâtel   The Canton of Neuchâtel will open up a new dual-mode training route…

Universität Bern

Bern Center for Artificial Intelligence in Medicine (CAIM)

A new platform in the field of Artificial Intelligence in medicine   The University of Bern & the Inselspital, Bern…

Universität Bern

Multidisciplinary Center for Infectious Diseases & Immunity (MCIDI)

Newly founded: MCIDI   The University of Bern established a multidisciplinary center to study the origin and course of infectious…

Zeta

ZETA | A new subsidiary in Switzerland (Visp, VS)

Switzerland is the Mecca of the pharmaceutical industry   ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages…

Distalmotion

Distalmotion | Received European CE mark for Dexter surgical robot

Dexter surgical robot  Distalmotion, a Swiss-based medical device company establishing a new global standard of care ensuring every patient can…

Debiopharm

Debiopharm | Phase II research against covid-19 launched

Antiviral Alisporivir: a valuable additional therapy to SOC   Debiopharm, a Swiss biopharmaceutical company, announced the first patient dosed in…

ADR-AC | A new testing service against the new Coronavirus 2019

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Swiss Medtech

Swiss Medtech | Award 2021

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL

EPFL | New synthetic molecule to kill the flu virus

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

EspeRare Pierre Fabre

EspeRare & Pierre Fabre | A pioneering treatment for XLHED

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Comphya

Comphya | Raised additional USD 1.3 million

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

ABCDx

ABCDx | Submit StrokeCheck for clearance in the US & EU

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

Lymphatica

Lymphatica Medtech | Raises seven-digit Series A round

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

SICHH

SICHH | BrainFit4Life project

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

Biopôle CSL Behring

CSL BEHRING REI & BIOPÔLE | A new collaboration partnership

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

Abionic

Abionic | Five-minutes test for scoring COVID-19 severity

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

HESAV Campus Santé

HESAV | A new Campus dedicated to Health

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

SEED Biosciences

SEED Biosciences | Completes CHF 1 mio. series A financing round

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…

Eyeware

Startup Eyeware | Products available all the way to Japan!

Eyeware has just entered into a partnership with the company Studio Uni    The startup Eyeware, hosted at IdeArk in…

Netsensing Technology

Netsensing Technology | Raised funds for it Home Sleep Apnea Test (HSAT)

Netsensing Technology secures a seed financing round to accelerate Home Sleep Apnea Test device development   Netsensing Technology Sàrl has…

COVID-19

SICHH | “Connect People with Science” platform

A new scientific communication platform   A new scientific communication platform entitled “Connect People with Science” is being launched. Its…

JSR Life Sciences

JSR | Expands its European Gene-to-GMP in Geneva

Geneva: 250 new highly technical jobs   JSR Life Sciences, LLC announced that it is increasing its European footprint with…

Plair SA MBV

Plair SA – MBV | Signature of a collaboration agreement

Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and…

EPFL

COVID-19 Testimonial Series | Laboratory of Biological Network Characterization (LBNC)

Next generation microfluidic devices for applications in molecular diagnostics   The following article is part of BioAlps’ testimonial series and…

Technology by Bilan 2020

Technology by Bilan 2020

Revolution in Healthcare | How robotics, virtual reality and artificial intelligence are improving the profession   Bilan, in partnership with…

EPFL

COVID-19 Testimonial Series | EPFL’s Laboratory of Microbiology and Microtechnology

Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments   The following article is part of BioAlps’…

CSL Behring

CSL Behring | Opening of a new manufacturing facility in Bern (Switzerland)

To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern   The new…

MaxiVAX

COVID-19 Testimonial Series | MaxiVAX

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series…

Sophia Genetics

SOPHiA GENETICS raises $110 million in oversubscribed new funding round

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader…

GaDia

COVID-19 Testimonial Series | GaDia

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial…

Coronasense

COVID-19 Testimonial Series | Coronasense

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections  …

CERN

COVID-19 Testimonial Series | CERN

Leveraging CERN’s novel technologies and know-how to develop health applications   The following article is part of BioAlps’ testimonial series…

SwissCovid

COVID-19 Testimonial Series | SwissCovid

SwissCovid app | Privacy by design   The following article is part of BioAlps’ testimonial series and was written by…

Takeda

COVID-19 Testimonial Series | Takeda Neuchâtel Manufacturing Site

Reorganisation of teams and work streams to ensure the production and delivery of life-saving products while protecting the health of…

HUG

COVID-19 Testimonial Series | HUG Innovation Center

Digital solutions, fundamental and clinical research, and organisational process redesign to support the fight against COVID and enhance the physicians-patients…

JAG

COVID-19 Testimonial Series | JAG Process Solutions

Development of vaccine, drugs and robotic disinfection equipment to fight COVID-19   The following article is part of BioAlps’ testimonial…

EBAMed

EBAMed annonces EUR 2.4 million grant

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad…

SwissKH

COVID-19 Testimonial Series | SwissKH

Swiss-made protective visor and door opening device to protect against COVID-19   The following article is part of BioAlps’ testimonial…

Vaccine Formulation Institute (VFI)

COVID-19 Testimonial Series | Vaccine Formulation Institute (VFI)

Open-access adjuvants and vaccine formulation expertise to benefit the whole community in the fight against COVID-19   The following article…

Aquanetto

COVID-19 Testimonial Series | AquaNetto

Fluid and surface disinfection sustainable modular solutions to fight against COVID-19   The following article is part of BioAlps’ testimonial…

UCB

COVID-19 Testimonial Series | UCB

Supporting patients, healthcare providers and communities worldwide through treatment and vaccine research, testing resources and donations   The following article…

Neurix

COVID-19 Testimonial Series | Neurix SA

A Swiss in vitro drug testing platform for the identification of potential treatments against coronavirus   The following article is…

UNIGE Biopharmaceutics

COVID-19 Testimonial Series | UNIGE Biopharmaceutics

Development of mRNA and DNA vaccines against COVID-19   The following article is part of BioAlps’ testimonial series and was…

Spentys

COVID-19 Testimonial Series | Spentys

High-quality 3D scanning, modelling, and printing solutions for healthcare providers   The following article is part of BioAlps’ testimonial series…

Norgren

COVID-19 Testimonial Series | Norgren (FAS)

Swiss manufacturer of liquid valves, syringe pumps and mass flow controllers supporting the high-level of demand in ventilators   The…

Combioxin SA

COVID-19 Testimonial Series | Combioxin SA

First-in-class life-saving drugs for severe infections   The following article is part of BioAlps’ testimonial series and was written by…

Helvetica Health Care

COVID-19 Testimonial Series | Helvetica Health Care

Marketing and distribution of a wide range of molecular controls and panels   The following article is part of BioAlps’…

PICC Solution

COVID-19 Testimonial Series | PICC Solution

How AI can support research by extracting, analysing and compiling data The following article is part of BioAlps’ testimonial series…

Embedded Systems Laboratory

COVID-19 Testimonial Series | Coughvid

How AI applied to cough recordings can help in the identification of COVID-19 cases   The following article is part…

Distillery Morand

COVID-19 Testimonial Series | Morand Distillery

From spirit production to hand sanitisers   The following article is part of BioAlps’ testimonial series and was written by…

SICHH

COVID-19 Testimonial Series | Swiss Integrative Center for Human Health (SICHH)

Adapting to become a satellite laboratory to carry out genetic testing of SARS-Cov-2 for the Fribourg Hospital (HFR)   The…

Daphne Technology

COVID-19 Testimonial Series | Daphne Technology

From exhaust gas cleaning system to easy-to-assemble face shield against COVID-19   The following article is part of BioAlps’ testimonial…

E4S

COVID-19 Testimonial Series | E4S

E4S’ Testimonial | A policy approach to fighting COVID-19   The following article is part of BioAlps’ testimonial series and…

Abionic

COVID-19 Testimonial Series | Abionic

A rapid sepsis test, the key to saving lives   The following article is part of BioAlps’ testimonial series and…

MedCo

COVID-19 Testimonial Series | MedCo

Secure, privacy-conscious data analytics among hospitals   The following article is part of BioAlps’ testimonial series and was written by…

Netsensing

COVID-19 Testimonial Series | Netsensing

Patients with sleep apnea are more at risk when infected with COVID-19   The following article is part of BioAlps’…

SIB Swiss Bioinformatics Institute

COVID-19 Testimonial Series | SIB Swiss Bioinformatics Institute

Bioinformatics, a crucial key to a rapid response to the COVID-19 threat   The following article is part of BioAlps’…

CSL Behring

COVID-19 Testimonial Series | CSL Behring

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by…

SOPHiA GENETICS and Dasa join forces to fight cancer

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA…

Eye imagery

Eye imagery revolutionised

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the…

Incyte inauguration 2020

Incyte gets installed in the canton of Vaud

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new…

Medtech

Artiria Medical raise CHF 3 million in series A

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and…

iOnctura

iOnctura raise €20 million for series A

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based…

EMBION

EMBION™ Technologies develops a new solution

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe

CoreMedica Europe | Enters the COVID-19 blood test race

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics…

Polares Medical

Polares Medical raises $40M

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a…

University of Bern

University of Bern Institute of Infectious Diseases (IFIK) opens a new laboratory

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University…

CoreMedica Laboratories

CoreMedica Laboratories Inc. implements Roche Elecsys antibody test for COVID-19

CoreMedica Laboratories Inc. provides COVID-19 serology confirmations via a secondary antibody detection method   On 12 June 2020, CoreMedica Laboratories,…

HMCare

HMCare to develop a transparent surgical mask

HMCare will launch the production of its HelloMask as of early 2021   For the past two years, the EPFL…

GliaPharm

GliaPharm raises CHF 1.5 million

GliaPharm reaches a total of CHF 2 million raised to further its drug development   On 25 May 2020, EPFL…

Bachem

Bachem supports the fight against COVID-19 worldwide

Bachem supplies key anaesthetic drug to support fight against COVID-19   The Swiss-based company, Bachem, is the world leader in…

BioAlps Networking Day 2020

Save the Date | BioAlps Networking Day

BioAlps Networking Day 2020 | Annual gathering of Western Switzerland’s Life Sciences’ Community   The event is planned to take…

Abionic

COVID-19 | Abionic’s solution, a life saver

Abionic’s sepsis test supports the fight against COVID-19   When the pandemic hit, Abionic was finalising a financing round to…

Lonza

Lonza & Moderna partner to produce COVID-19 vaccine

Lonza | A key player in the COVID-19 vaccine production   Lonza, the Valais-based company, has signed a 10 year…

SILAB

Partnership offer for SNF NRP78 “Covid-19” call

SNF NRP78 « Covid-19 » Call | Collaboration opportunity with SILAB   SILAB can be a real asset to develop…

ADC Therapeutics

ADC Therapeutics goes public

ADC Therapeutics chooses the New York Stock Exchange   On 15 May 2020, the Biopôle-based company, ADC Therapeutics went public….

AquaNetto | Extended use of the same mask

AquaNetto enables you to wear the same mask for an extended period of time   Based in the canton of…

COVID-19

Incyte & Novartis enter phase II trials with Jakafi drug

Partners are taking Jakafi drug into a second late-stage trial for COVID-19 patients on ventilators   On 5 May 2020,…

COVID-19

COVID-19 | AIDES POUR LES START-UP

In light of the COVID-19 situation, we are exceptionally posting information in French on our website. Do not hesitate to…

HUG Clinical Trial

COVID-19 | HUG launch a clinical trial

HUG | Preventive treatment for people in contact with COVID-19 patients   The HUG launch a clinical trial called CoPEP…

Medtronic

Medtronic shares ventilator specifications

Medtronic is publicly sharing design specifications for its ventilators to support the fight against COVID-19   Medtronic is sharing the…

COVID-19

A simultaneous diagnostic test for COVID-19, flu and SRAS infections

Adamant Innotech and CSEM develop a simultaneous diagnostic test for past COVID-19, flu and SRAS infections   On 9 April…

Quotient Limited

Quotient Limited | SARS-CoV-2 Antibody Test

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development   Vaud-based Quotient Limited announced on 6 April 20202,…

Augurix GaDia

Augurix and GaDia develop a rapid COVID-19 serological test

First rapid COVID-19 serological test to enter Swiss market   On 6 April 2020, Augurix SA and GaDia announce the…

Gnubiotics

Gnubiotics joins the fight against COVID-19

Gnubiotics accelerates testing of multivalent-glycan based pipeline candidates against viral entry of COVID-19   Since 2016, Gnubiotics has invested in…

COVID-19

COVID-19 | MESURES ECONOMIQUES

In light of the COVID-19 situation, we are exceptionally posting the information in French on our website. Do not hesitate…

Aktiia

Aktiia raises CHF 6 million

Aktiia raises new funds to finalise last steps towards market entry   Neuchâtel-based Aktiia, created in 2018, has developed a…

Medtech

New EU Medical Devices Regulation to be delayed by a year

European Commission seeks to delay the new EU Medical Devices Regulation (MDR)   Stella Kyriakides, the European Commissioner for Health…

Swiss Medtech

Information from Swiss Medtech

Swiss Medtech companies defined as part of Switzerland’s critical infrastructure   The Federal Department of Defence, Civil Protection and Sport…

Rheon Medical

Rheon Medical acquires the CE Marking

Rheon Medical to launch its eyeWatch product on the Swiss and EU markets   The Vaud-based startup, Rheon Medical, specialised…

1Drop

1Drop Diagnostics to board the International Space Station

1Drop brings medical diagnostics to space   The Neuchâtel-based company, 1Drop Diagnostics, which specialises in the detection of cardiovascular biomarkers…

Neuro

UNIFR & SICHH | New Alzheimer’s diagnosis

Teams from UNIFR & SICHH discover a new Alzheimer diagnosis solution based on saliva analysis   The University of Fribourg…

Abionic

Abionic’s sepsis test | A diagnosis solution for the new Coronavirus

Abionic’s R&D focuses on the development of an early sepsis diagnosis solution | A tool for Coronavirus identification   Abionic,…

EBAMed joins the Mayo Clinic Business Accelerator

EBAMed joins the Mayo Clinic Business Accelerator and starts pre-clinical testing   EBAMed SA, a medical technology company enabling access…

Cordsavings

Cordsavings | A Decisive Alliance in Stem Cell Biobanking

Los Angeles – Geneva – Monthey: CSG-BIO SA (CSG-Bio), which intends to offer the most advanced and comprehensive stem cell banking services to families worldwide in the near future, took over some of CryoSave AG’s assets in 2019. It has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, to secure the hundreds of thousands of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.

SOPHiA GENETICS

SOPHiA GENETICS Appoints Chief Medical Officer

New appointment at SOPHiA GENETICS to accelerate the execution of its Medical Strategy   On 13 February 2020, SOPHiA GENETICS, leader…

Lunaphore

Lunaphore raises CHF 23 million

Lunaphore closes its Series C funding   On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the…

New GE Healthcare manufacturing site in western Switzerland

New centre of excellence in the canton of Vaud | GE Healthcare Life Sciences   GE Healthcare Life Sciences will…

CSEM

ORGANTRANS | A milestone in regenerative medicine

Creation of a European Consortium | ORGANTRANS   On 4 February 2020, the CSEM announced the creation of  the European project ORGANTRANS….

Swiss Venture Capital Report 2020

Swiss Venture Capital Report 2020

The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors   The 8th…

Novostia

Novostia receives grant from the European Commission

European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups   The European Commission selected 75 startups…

GeNeuro

GeNeuro closes €17.5 million private placement

GeNeuro secures investment to further clinical trials   GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing…

Endotelix Diagnostics

Endotelix Diagnostics wins VentureKick Stage 3

Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome   In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects.  …

Merck

Merck invests €250 million in Switzerland

Merck Biotech Development Center | New Facility in Switzerland   On 27 January 2020, Merck announced a €250 million investment…

Nanolive

Nanolive is moving to a new office location

Another milestone for Nanolive, as the company moves to new offices   In 2013, Nanolive started its adventure in a…

Abionic

Abionic | Hitting the European and US markets

Abionic to commercialise its rapid sepsis diagnosis product on the EU and US markets   The Abionic team, who has…

SILAB

NTN Innovation Booster | Contribute to the Future of Healthcare with SILAB

Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow   Innovation…

qmt

Qualimatest & SAPHIR join forces to become qmt

qmt | The industry’s quality test and control reference   On 9 January 2020, SAPHIR and Qualimatest announced that their…

Healthcare Konnect

Oxipit partners with HealthCare Konnect | Press Release

Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria. The partnership aims to introduce vanguard AI diagnostic capabilities and improve detection of 75 pathologies, including tuberculosis, to one of the largest markets in Africa.

IDT partners with SOPHiA GENETICS

IDT partners with SOPHiA GENETICS | Press Release

Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and patients

BioAlps Networking Day 2019

BioAlps Networking Day 2019 Interviews

BioAlps Networking Day 2019 | Discover key speaker interviews by GGBa   The Greater Geneva Bern area (GGBa) collaborated with BioAlps once…

Neuro

NeuroRestore Center is launched

NeuroRestore Center | A new partnership to restore neurological functions through research, innovation and treatment   Defitech Foundation is partnering with…

Brain-Computer Interface

Brain-Computer Interface Technologies by Claude Clément

Brain-Computer Interface Technologies | Accelerating Neuro-Technology for Human Benefit The BioAlps team is proud to present our President’s new book….

Smart Protein

HES-SO Valais | Smart Protein Project

Smart Protein Project | In search of a meat substitute   HES-SO Valais was selected to take part in the Smart…

Positive Coating

POSITIVE COATING – 15 positive years

Fondée en 2004, POSITIVE COATING se distingue par le développement de solutions innovantes dans le domaine des traitements de surfaces basés sur les technologies PVD (Physical Vapor Deposition) et ALD (Atomic Layer Deposition), des traitements physiques et chimiques de pointe. A l’occasion de son 15-ème anniversaire, elle revient sur les grandes étapes de son parcours et donne la parole à sa direction afin qu’elle nous explique l’origine de son nom et les valeurs de l’entreprise qui ont été moteur de son succès.

microcity

Swiss serial entrepreneur joins Microcity Startup Program

Marc Thurner, founder of regenHU, Vivos Dental and mimix biotherapeutics joins Microcity as Stratup Program Manager   In October 2019,…

Entreprise Romande

Entreprise Romande – The rise of Life Sciences

The rise of Life Sciences in the past 20 years by Entreprise Romande Everything you need to know   Discover…

Agefi

Agefi – Journey to the future of healthcare professions

How will the future of healthcare professions be affected by new technologies?   Agefi’s article provides insider knowledge regarding the…

GTX Medical

GTX Medical enters the US market

“The EPFL spin-off GTX Medical moves into the US market”   The Health Valley based startup, GTX Medical, which developed…

SOPHiA GENETICS Expands it’s Executive Team

A new Chief Marketing Officer and a new Chief Information Officer have joined SOPHiA GENETICS’ Executive Team SOPHiA GENETICS, leader in…

EPFL

EPFL : The path of breast-to-brain cancer metastasis

EPFL scientists have discovered the path used by breast cancer cells to metastasize to the brain   One of the…

Fresenius Kabi

Fresenius Kabi expands biosimilar research activities in Eysins

Fresenius Kabi expands biosimilar research activities – Inauguration of state-of-the-art R&D center in Eysins, Switzerland   On 18 September 2019,…

Virdis Group

Virdis Group furthers Swiss expansion

Virdis Group announces new office opening in Lausanne, Switzerland to further Swiss expansion.

Healthcare Konnect

CureMetrix and HealthCare Konnect join forces

LA JOLLA, California, (Aug 29, 2019) – CureMetrix® a healthcare technology company that develops computer-aided detection (CAD) artificial intelligence (AI) based radiology software, announced that it entered into an agreement with HealthCare Konnect, to bring CureMetrix AI technologies to healthcare institutions in Nigeria and Algeria. The organizations will collaborate to support the clinical advancement of AI technologies to improve breast cancer detection in these regions.

University of Fribourg

Fribourg University Launches A New Master of Medicine

A new Master of Medicine was launched this autumn at Fribourg University, designed in collaboration with the Fribourg Hospital (HFR)…

Abionic

Efficiency Proof of Abionic’s Revolutionizing Sepsis Diagnosis Solution

International pivotal study successfully demonstrates Abionic’s diagnosis of sepsis within 5 minutes – 24 hours earlier compared with current standard-of-care…

EPFL

At EPFL AI fosters synergy between man and robot

EPFL scientists are using AI to improve control over robotic hand use for amputees   Artificial Intelligence (AI) is used…

HUG

Artificial Intelligence supporting HUG’s cancer treatment solutions

This year, HUG have implemented Watson for Genomics: the search engine based on tumour genetic information   Watson for Genomics…

Abionic

Abionic Signs Agreement with Genentech

Abionic and Genentech have signed an agreement to develop and provide rapid Point-of-Care tests for Asthma in the US  …

Swiss-based startup EBAMed raises CHF 1.2 Million

Funding supports development of first integrated heart motion management
system and pre-clinical testing

Drug Delivery

A glass needle gives new hope

A minuscule needle synonymous of hope for 16 million patients   FEMTOprint has developed, in partnership with the EPFL and…

ADC Therapeutics and SOPHiA GENETICS partner for biomarker discovery

ADC Therapeutics and SOPHiA GENETICS Partner in Pivotal Phase II Clinical Trial   Study to identify genomic markers associated with…

HUG

A magical healing sponge

HUG‘s Experimental Cell Therapy Lab has developed a stem cell based magical healing sponge   The bioabsorbable sponge has proven…

CHUV

Professor Solange Peters & team receive the Bonnie J. Addario 2019 prize

CHUV Professor Solange Peters & team were granted this year’s GO2 Foundation prize   This year’s Bonnie J. Addario prize…

Smart Protein

Pharma industry is boosting Swiss exports

Pharma products take first place on the Swiss export board   The high demande from international markets drives Swiss pharma…

Pryv and BGO launch privacy-centric eCRF solution

The innovative RWD eConsent solution is ideal for enhancing clinical trials with Real-World Data (RWD), achieving privacy compliance and improving patients’ engagement.

Switzerland, Morges, 12 June 2019 – Pryv, the leading Swiss provider of privacy and personal data management software, and BGO Software, a Bulgaria-based leading software services and product development company, have announced the launch of an innovative eCRF solution to manage Real-World Data (RWD) and informed electronic consent (eConsent).

UNIGE HUG

New head of UNIGE’s Faculty of Medicine and HUG’s Teaching and Research Department

Professor Cem Gabay has been appointed as the new Dean of the Faculty of Medicine (UNIGE) and Head of the…

AMAL Therapeutics acquired by Boehringer Ingelheim

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform   Boehringer Ingelheim announced…

CSEM

A “smart bra” for detecting breast cancer

Introducing the SBRA “smart bra” project   The SBra project aims to develop an intelligent bra, equipped with sensors, capable…

Sophia Genetics

SOPHiA GENETICS welcomes Troy Cox to its Board of Directors

Troy Cox joins SOPHiA GENETICS as the company expands its decentralized approach to Data-Driven Medicine to foster a sustainable and…

UNIGE – Medicines made of solid gold

Medicines made of solid gold to help the immune system   By studying the effects of gold nanoparticles on the…

UNIGE

UNIGE – Detecting problems of the anti-bleeding system in 60 minutes

UNIGE and Franche-Comté University researchers have co-developped an innovative device enabling platelet capacity detection   This tool investigates a patient’s…

UNIGE

UNIGE : Yves Flückiger appointed as Rector for a second term

The appointment of the new rectorate of UNIGE by the Council of State was revealed on Thursday 20 June 2019.   Prof….

The Wyss Center has a new Director

Dr Mary Tolikas has been appointed as the new Director of the Wyss Center   “The Executive Board of the…

UNIGE and UNIL : “A model to decipher the complexity of gene regulation”

Scientist at the Universities of Geneva and Lausanne, Switzerland, designed a framework to analyse gene regulation, and offer a model…

Asceneuron : New member appointed to the Board of Directors

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today announces the appointment of Dr Eric Yuen to its Board of Directors.

The 2019 Global Startup Ecosystem Report is now available!

The Bern-Lausanne-Geneva region has been ranked #22 worldwide in this year’s edition of the Global Startup Ecosystem Report   Not only…

SICHH

The Swiss Integrative Center for Human Health (SICHH) and the Human Brain Project (HBP) unite

The SICHH and the HBP unite to further research on Alzheimer’s disease and dementia.   The SICHH welcomes the HBP…

Deep Cube – A Success Story

Watch Deep Cube‘s video and learn more about one the canton of Vaud’s striving startups!        

Back to the sources of neural diversity

By deciphering the genetic programmes of neurons of the cerebral cortex, Swiss and Belgian researchers unravel the mechanisms controlling the…

Avatarion will be present at the Digital Heath Connect

Avatarion : Robots in healthcare   The Digital Health Connect will take place on 7 June in Sierre in the…

EPFL Innovation Park

The startup as an innovative partner

Creating bridges between a large corporation and start-ups is not always an easy task. However, this becomes indispensable to ensure its capacity for innovation. For example, if one is an insurer, seeking to enhance the value of billions of medical data to help your clients stay healthy, developing partnerships with start-ups specializing in artificial intelligence is necessary. It is no longer possible to do everything internally. So how to make these bridges less slippery?

A natural barrier which prevents tumors from metastasizing

EPFL scientists have discovered a natural barrier which